相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Inducing apoptosis in chemotherapy-resistant B-lineage acute lymphoblastic leukaemia cells by targeting HSPA5, a master regulator of the anti-apoptotic unfolded protein response signalling network
Fatih M. Uckun et al.
BRITISH JOURNAL OF HAEMATOLOGY (2011)
Novel Proteasome Inhibitors to Overcome Bortezomib Resistance
Amy M. Ruschak et al.
JOURNAL OF THE NATIONAL CANCER INSTITUTE (2011)
AMPK and Akt Determine Apoptotic Cell Death following Perturbations of One-Carbon Metabolism by Regulating ER Stress in Acute Lymphoblastic Leukemia
Jeffim N. Kuznetsov et al.
MOLECULAR CANCER THERAPEUTICS (2011)
GSI-I (Z-LLNle-CHO) inhibits γ-secretase and the proteosome to trigger cell death in precursor-B acute lymphoblastic leukemia
X. Meng et al.
LEUKEMIA (2011)
Successful T-cell acute lymphoblastic leukemia treatment with proteasome inhibitor bortezomib based on evaluation of nuclear factor-κB activity
Xiaohui Hu et al.
LEUKEMIA & LYMPHOMA (2011)
NF-κB addiction and its role in cancer: 'one size does not fit all'
M. M. Chaturvedi et al.
ONCOGENE (2011)
Prophylactic antibiotics for the prevention of neutropenic fever in patients undergoing autologous stem-cell transplantation: Results of a single institution, randomized phase 2 trial
Evangelos Eleutherakis-Papaiakovou et al.
AMERICAN JOURNAL OF HEMATOLOGY (2010)
Building on bortezomib: second-generation proteasome inhibitors as anti-cancer therapy
Lawrence R. Dick et al.
DRUG DISCOVERY TODAY (2010)
Proteasome Inhibitor PS-341 (Bortezomib) Induces Calpain-dependent IκBα Degradation
Chunyang Li et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2010)
Outcome of Patients Treated for Relapsed or Refractory Acute Lymphoblastic Leukemia: A Therapeutic Advances in Childhood Leukemia Consortium Study
Richard H. Ko et al.
JOURNAL OF CLINICAL ONCOLOGY (2010)
Phase I Study of Bortezomib Combined With Chemotherapy in Children With Relapsed Childhood Acute Lymphoblastic Leukemia (ALL): A Report From the Therapeutic Advances in Childhood Leukemia (TACL) Consortium
Yoav Messinger et al.
PEDIATRIC BLOOD & CANCER (2010)
Bortezomib induces canonical nuclear factor-κB activation in multiple myeloma cells
Teru Hideshima et al.
BLOOD (2009)
Reversibility of symptomatic peripheral neuropathy with bortezomib in the phase III APEX trial in relapsed multiple myeloma: impact of a dose-modification guideline
Paul G. Richardson et al.
BRITISH JOURNAL OF HAEMATOLOGY (2009)
Prophylactic antibiotics reduce morbidity due to septicemia during intensive treatment for pediatric acute myeloid leukemia
Beth Kurt et al.
CANCER (2008)
Reinduction platform for children with first marrow relapse in acute lymphoblastic lymphoma
Elizabeth A. Raetz et al.
JOURNAL OF CLINICAL ONCOLOGY (2008)
Severe pulmonary complications after bortezomib treatment for multiple myeloma: An unrecognized pulmonary vasculitis?
Vincenzo Pitini et al.
LEUKEMIA RESEARCH (2007)
A phase 1 study of the proteasome inhibitor bortezomib in pediatric patients with refractory leukemia: A Children's Oncology Group study
Terzah M. Horton et al.
CLINICAL CANCER RESEARCH (2007)
Development of fatal bortezomib induced acute lung injury despite concurrent therapy with high-dose dexamethasone
Edward Chew et al.
LEUKEMIA & LYMPHOMA (2007)
Proteasome inhibitors: antitumor effects and beyond
A. Nencioni et al.
LEUKEMIA (2007)
Bortezomib interactions with chemotherapy agents in acute leukemia in vitro
TM Horton et al.
CANCER CHEMOTHERAPY AND PHARMACOLOGY (2006)
Bone marrow transplantation versus prolonged intensive chemotherapy for children with acute lymphoblastic leukemia and an initial bone marrow relapse within 12 months of the completion of primary therapy: Children's Oncology Group Study CCG - 1941
Paul S. Gaynon et al.
JOURNAL OF CLINICAL ONCOLOGY (2006)
Severe pulmonary complications in Japanese patients after bortezomib treatment for refractory multiple myeloma
S Miyakoshi et al.
BLOOD (2006)
Childhood acute lymphoblastic leukaemia and relapse
PS Gaynon
BRITISH JOURNAL OF HAEMATOLOGY (2005)
Levofloxacin to prevent bacterial infection in patients with cancer and neutropenia
G Bucaneve et al.
NEW ENGLAND JOURNAL OF MEDICINE (2005)
Antibacterial prophylaxis after chemotherapy for solid tumors and lymphomas
M Cullen et al.
NEW ENGLAND JOURNAL OF MEDICINE (2005)
Phase I study of bortezomib in refractory or relapsed acute leukemias
J Cortes et al.
CLINICAL CANCER RESEARCH (2004)
Proteasome inhibitors disrupt the unfolded protein response in myeloma cells
AH Lee et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2003)
Molecular sequelae of proteasome inhibition in human multiple myeloma cells
N Mitsiades et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2002)
分享论文
